Jay M Sosenko (Jay Sosenko)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Topics

Genome Wide Association Study

Top Venues

Pediatric diabetes

This page only lists publications with an associated author ORCID identifier.

Publications

Jay M Sosenko, David Cuthbertson, Emily K Sims, Heba M Ismail, Brandon M Nathan, Michael J Haller, Mark A Atkinson, Carmella Evans-Molina, Kevan C Herold, Jay S Skyler, Maria Jose Redondo, null null
Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies. Diabetes care (2023)
Emily K Sims, David Cuthbertson, Kevan C Herold, Jay M Sosenko
The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes. Diabetes 70 (12) (2021)
Jamie L Felton, David D Cuthbertson, Megan Warnock, Kuldeep Lohano, Farah Meah, John M Wentworth, Jay M Sosenko, Carmella Evans-Molina, null null
HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants. Diabetologia 65 (1) (2021)
Isaac Snowhite, Ricardo Pastori, Jay M Sosenko, Shari Messinger Cayetano, Alberto Pugliese
Baseline Assessment of Circulating MicroRNAs Near Diagnosis of Type 1 Diabetes Predicts Future Stimulated Insulin Secretion. Diabetes 70 (2) (2020)
Heba M Ismail, Mario A Cleves, Ping Xu, Ingrid M Libman, Dorothy J Becker, Jennifer B Marks, Jay S Skyler, Jerry P Palmer, Jay M Sosenko, null null
The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study. Diabetes care 43 (11) (2020)
Jay M Sosenko, Jay S Skyler, Kevan C Herold, Desmond A Schatz, Michael J Haller, Alberto Pugliese, Mario Cleves, Susan Geyer, Lisa E Rafkin, Della Matheson, Jerry P Palmer, null null
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials. Diabetes 69 (8) (2020)
Maria Jose Redondo, Carmella Evans-Molina, Andrea K Steck, Mark A Atkinson, Jay M Sosenko
The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes. Diabetes care 42 (8) (2019)
Heba M Ismail, Carmella Evans-Molina, Linda A DiMeglio, Dorothy J Becker, Ingrid Libman, Emily K Sims, David Boulware, Kevan C Herold, Lisa Rafkin, Jay Skyler, Mario A Cleves, Jerry Palmer, Jay M Sosenko, null null
Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes. Pediatric diabetes 20 (4) (2019)
Maria Jose Redondo, Andrea K Steck, Jay M Sosenko, Mark Anderson, Peter Antinozzi, Aaron W Michels, John M Wentworth, Mark A Atkinson, Alberto Pugliese, Susan Geyer, null null
Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes. Diabetes care 41 (12) (2018)
Maria Jose Redondo, Susan Geyer, Andrea K Steck, Seth Sharp, John M Wentworth, Michael N Weedon, Peter Antinozzi, Jay M Sosenko, Mark Atkinson, Alberto Pugliese, Richard A Oram, null null
A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes care 41 (9) (2018)
Brandon M Nathan, David Boulware, Susan Geyer, Mark A Atkinson, Peter Colman, Robin Goland, William Russell, John M Wentworth, Darrell M Wilson, Carmella Evans-Molina, Diane Wherrett, Jay S Skyler, Antoinette Moran, Jay M Sosenko, null null
Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials. Diabetes care 40 (11) (2017)
Maria Jose Redondo, Susan Geyer, Andrea K Steck, Jay M Sosenko, Mark Anderson, Peter Antinozzi, Aaron Michels, John Wentworth, Ping Xu, Alberto Pugliese, null null
TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes care 41 (2) (2017)
Jay M Sosenko, Susan Geyer, Jay S Skyler, Lisa E Rafkin, Heba M Ismail, Ingrid M Libman, Yuk-Fun Liu, Linda A DiMeglio, Carmella Evans-Molina, Jerry P Palmer
The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1. Pediatric diabetes 19 (3) (2017)